Olema, Novartis and metastatic breast cancer
Researchers at Baylor College of Medicine and Rice University have received a $2.3 million Breakthrough Award from the ...
A study from researchers at the University of Michigan and the University of California San Diego has shed light on a ...
The Data Safety Monitoring Board (DSMB) stated no safety concerns, and recommended continuation of BriaCell’s pivotal Phase 3 study of Bria-IMT™ ...
The phase 1/2 study will assess next-generation immunotherapy alone and in combination with an immune checkpoint inhibitor in ...
Barbara O’Brien, MD, discusses the next steps of the phase 2 TBCRC049 study for the treatment of patients with HER2-positive ...
On Nature published the results of an innovative breast cancer research project from the Netherlands. This study, the SONIA ...
The "Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about 10+ ...
An expert discusses the next steps for patients with metastatic breast cancer after their disease no longer responds to ...
Linda D’Addario, a cancer survivor, now mentors others through Cancer Hope Network, a program now available at five area ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback